Correspondence 0001104659-23-120401 from Kiniksa Pharmaceuticals International, plc (KNSA) (CIK 0001730430) (KNSA)
Kiniksa Pharmaceuticals International, plc (KNSA) (CIK 0001730430)
Date: Nov. 21, 2023 · CIK: 0001730430 · Accession: 0001104659-23-120401
AI Filing Summary & Sentiment
File numbers found in text: 001-38492
Letter
Division of Corporation Finance Office of Life Sciences Securities and Exchange Commission Re: Kiniksa Pharmaceuticals, Ltd. Form 10-K for the fiscal year ended December 31, Filed March 2, 2023 File No. 001-38492
Dear Mr. Wyman and Ms. Ignat:
The comment letter received by Kiniksa Pharmaceuticals, Ltd., a Bermuda exempted company (the “Company”) from the Staff of the Securities and Exchange Commission (the “SEC”), dated November 16, 2023, regarding the above-referenced Form 10-K requests that the Company respond within ten business days or advise the Staff when the Company will respond. The Company is working to address the points in the comment letter but requires additional time to complete its responses. In order to fully respond to the comment letter, the Company believes it will need until December 14, 2023. We appreciate the Staff’s willingness to allow for the additional time.
Please contact the undersigned at 617-951-7980 should you require any additional information regarding this matter.
Sincerely,
/s/ Marko Zatylny
Show Raw Text
CORRESP
1
filename1.htm
ROPES & GRAY LLP
PRUDENTIAL TOWER
800 BOYLSTON STREET
BOSTON, MA 02199-3600
WWW.ROPESGRAY.COM
November 21, 2023
Frank Wyman
Ibolya Ignat
Division of Corporation Finance
Office of Life Sciences
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-9303
Re:
Kiniksa Pharmaceuticals, Ltd.
Form 10-K for the fiscal year ended December 31,
2022
Filed March 2, 2023
File No. 001-38492
Dear Mr. Wyman and Ms. Ignat:
The comment letter received by Kiniksa Pharmaceuticals, Ltd.,
a Bermuda exempted company (the “Company”) from the Staff of the Securities and Exchange Commission (the “SEC”),
dated November 16, 2023, regarding the above-referenced Form 10-K requests that the Company respond within ten business days
or advise the Staff when the Company will respond. The Company is working to address the points in the comment letter but requires additional
time to complete its responses. In order to fully respond to the comment letter, the Company believes it will need until December 14,
2023. We appreciate the Staff’s willingness to allow for the additional time.
Please contact the undersigned at 617-951-7980
should you require any additional information regarding this matter.
Sincerely,
/s/ Marko Zatylny
Marko Zatylny
Ropes & Gray LLP
cc:
Mark Ragosa
Maddy Zeylikman